Abstract:BACKGROUND Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to millions of confirmed cases and deaths worldwide. Elderly patients are at high risk of developing and dying from COVID-19 due to advanced age, decreased immune function, intense inflammatory response, and comorbidities. Shanghai has experienced a wave of infection with Omicron, a new variant of SARS-CoV-2, since March 2022. There is a pressing need to identify clinical features and risk factors for disease progression among elderly patients with Omicron infection to provide solid evidence for clinical policy-makers, public health officials, researchers, and the general public. AIM To investigate clinical characteristic differences and risk factors between elderly patients with severe and nonsevere Omicron SARS-CoV-2 variant infection. METHODS A total of 328 elderly patients with COVID-19 admitted to the Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine from April 2022 to June 2022 were enrolled and divided into a severe group (82 patients) and a nonsevere group (246 patients) according to the diagnosis and treatment protocol of COVID-19 (version 7). The clinical data and laboratory results of both groups were collected and compared. A chi-square test, t test, Mann-Whitney U test, hierarchical log-rank test, univariate and multivariate logistic regression, and hierarchical analyses were used to determine significant differences. RESULTS The severe group was older (84 vs 74 years, P < 0.001), included more males (57.3% vs 43.9%, P = 0.037), had a lower vaccination rate (P < 0.001), and had a higher proportion of comorbidities, including chronic respiratory disease (P = 0.001), cerebral infarction (P < 0.001), chronic kidney disease (P = 0.002), and neurodegenerative disease (P < 0.001), than the nonsevere group. In addition, severe disease patients had a higher inflammatory index (P < 0.001), greater need for symptomatic treatment (P < 0.001), longer hospital stay (P = 0.011), extended viral shedding time (P = 0.014), and higher mortality than nonsevere disease patients (P < 0.001). No difference was observed in the application of Paxlovid in the severe and nonsevere groups (P = 0.817). Oxygen saturation, cerebral infarction, and D-dimer were predictive factors for developing severe disease in patients with COVID-19, with D-dimer having an excellent role (area under the curve: 90.1%, 95%CI: 86.1-94.0%). In addition, D-dimer was a risk factor for developing severe COVID-19 according to multivariate stratified analysis. CONCLUSION The clinical course of severe COVID-19 is complex, with a higher need for symptomatic treatment. D-dimer is a suitable biomarker for identifying patients at risk for developing severe COVID-19.

Characterizing Distinct Profiles of Immune and Inflammatory Response with Age to Omicron Infection.

A diagnostic model for serious COVID-19 infection among older adults in Shanghai during the Omicron wave

Aging brought additional immune response alterations after breakthrough infections with the Omicron BA.5/BF.7 variants: Protein immune mechanism

Age- and Severity-Associated Humoral Immunity Response in COVID-19 Patients: A Cohort Study from Wuhan, China

Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 Immunopathology

Identifying Age-Related Risk Factors in COVID-19 Independent of Disease Severity

Analysis of Clinical Characteristics of 144 Patients Infected with SARS-Cov-2 Omicron Variant at Different Ages in Suzhou at the Beginning of 2022

Analysis of Epidemiological and Clinical Features in Older Patients with Coronavirus Disease 2019 (COVID-19) Outside Wuhan

Comparative Analysis of Clinical Characteristics, Imaging and Laboratory Findings of Different Age Groups with COVID-19.

Comparison of Clinical and Para-Clinical Characteristics Between Children and Adults with the Omicron Variant of COVID-19

Immunological characteristics in elderly COVID-19 patients: a post-COVID era analysis

Clinical characteristics and high risk factors of patients with Omicron variant strain infection in Hebei, China

Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection

Association between levels of IgG antibodies from vaccines and Omicron symptomatic infection among children and adolescents in China

Epidemiological and laboratory characteristics of Omicron infection in a general hospital in Guangzhou: a retrospective study

Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients

Analysis of Clinical Characteristics and Risk Factors Between Elderly Patients with Severe and Nonsevere Omicron Variant Infection

Characteristics of Immune and Inflammatory Responses among Different Age Groups of Pediatric Patients with COVID-19 in China.

Age Related Differences in Monocyte Subsets and Cytokine Pattern during Acute COVID-19-A Prospective Observational Longitudinal Study

[Periodic Dynamic Observation and Analysis of Cellular and Humoral Immunity Indexes of Adults Infected with Omicron BA.1].

Identification of Gene Signatures Associated with COVID-19 across Children, Adolescents, and Adults in the Nasopharynx and Peripheral Blood by Using a Machine Learning Approach